Rock Springs Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,000
Closed -$2.45M 161
2020
Q3
$2.45M Sell
9,000
-116,000
-93% -$31.6M 0.06% 139
2020
Q2
$36.3M Hold
125,000
1% 39
2020
Q1
$29.7M Sell
125,000
-78,000
-38% -$18.6M 1.23% 32
2019
Q4
$44.4M Hold
203,000
1.4% 16
2019
Q3
$34.4M Hold
203,000
1.37% 21
2019
Q2
$37.2M Hold
203,000
1.35% 19
2019
Q1
$37.3M Hold
203,000
1.44% 15
2018
Q4
$33.6M Buy
203,000
+7,000
+4% +$1.16M 1.59% 14
2018
Q3
$37.8M Buy
196,000
+5,500
+3% +$1.06M 1.37% 15
2018
Q2
$32.4M Buy
190,500
+9,500
+5% +$1.61M 1.25% 21
2018
Q1
$29.5M Buy
181,000
+9,750
+6% +$1.59M 1.26% 22
2017
Q4
$25.7M Buy
171,250
+19,750
+13% +$2.96M 1.16% 26
2017
Q3
$23M Buy
151,500
+22,500
+17% +$3.42M 1.06% 26
2017
Q2
$16.6M Buy
129,000
+38,500
+43% +$4.96M 0.84% 44
2017
Q1
$9.9M Buy
90,500
+750
+0.8% +$82K 0.57% 58
2016
Q4
$6.61M Hold
89,750
0.44% 65
2016
Q3
$7.83M Buy
89,750
+4,250
+5% +$371K 0.49% 58
2016
Q2
$7.36M Buy
85,500
+1,600
+2% +$138K 0.54% 57
2016
Q1
$6.67M Buy
83,900
+11,150
+15% +$886K 0.56% 57
2015
Q4
$9.15M Buy
72,750
+500
+0.7% +$62.9K 0.69% 51
2015
Q3
$7.52M Buy
72,250
+4,250
+6% +$443K 0.61% 60
2015
Q2
$8.4M Hold
68,000
0.61% 60
2015
Q1
$8.02M Buy
68,000
+5,000
+8% +$590K 0.75% 46
2014
Q4
$7.48M Buy
63,000
+5,500
+10% +$653K 0.88% 41
2014
Q3
$6.46M Buy
57,500
+11,250
+24% +$1.26M 1% 33
2014
Q2
$4.38M Buy
46,250
+30,250
+189% +$2.86M 0.79% 47
2014
Q1
$1.13M Sell
16,000
-4,000
-20% -$283K 0.26% 70
2013
Q4
$1.49M Buy
+20,000
New +$1.49M 0.53% 52